Impact of Prophylaxis for Mycobacterium avium Complex on Bacterial Infections in Patients with Advanced Human Immunodeficiency Virus Disease
Open Access
- 1 June 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (11) , 1615-1622
- https://doi.org/10.1086/320515
Abstract
The epidemiology and natural history of bacterial infections among ambulatory patients with advanced human immunodeficiency virus (HIV) disease has not been well described. In this prospective study, 394 subjects were enrolled and followed at 8-week intervals for a median of 21 months. During follow-up, 164 (42%) of 394 patients developed at least 1 bacterial infection. The most common infections were sinusitis, bacterial pneumonia, skin and soft tissue infection, and bronchitis. Serious bacterial infections (defined as bacterial pneumonia, bacteremia, or deep visceral abscess) were reported by 56 subjects (14%). Female sex, age of <40 years, and Karnofsky score of ⩽80 were independent risk factors for bacterial infections. Prophylaxis with clarithromycin, trimethoprim and sulfamethoxazole, or both had significant protective effect. The occurrence of any confirmed bacterial infection was associated with a significantly increased risk of mortality. This study documents that bacterial infections are common among patients with advanced HIV disease, especially among women.Keywords
This publication has 28 references indexed in Scilit:
- Clarithromycin or Rifabutin Alone or in Combination for Primary Prophylaxis ofMycobacterium aviumComplex Disease in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled TrialThe Journal of Infectious Diseases, 2000
- Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Rapid Communication: A Study of HIV RNA Viral Load in AIDS Patients with Bacterial PneumoniaJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Prophylaxis against DisseminatedMycobacterium aviumComplex with Weekly Azithromycin, Daily Rifabutin, or BothNew England Journal of Medicine, 1996
- Serious Pseudomonas aeruginosa Infections in Patients Infected with Human Immunodeficiency Virus: A Case-Control StudyClinical Infectious Diseases, 1994
- Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDSNew England Journal of Medicine, 1993
- A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- Clinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- ErratumAIDS, 1992
- Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDSAIDS, 1988